The effect of collateral flow and myocardial viability on the distribution of technetium-99m sestamibi in a closed-chest model of coronary occlusion and reperfusion

European Journal of Nuclear Medicine

Volumn 27, Issue 5, 2000, Pages 508-516

  Chareonthaitawee, Panithaya ^a,b   O'Connor, Michael K ^b   Gibbons, Raymond J ^b   Ritman, Erik L ^b   Christian, Timothy F ^b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b MAYO CLINIC   (United States)

Author keywords

Collateral circulation; Ischaemia; Radionuclide imaging; Viability Reperfusion

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MICROSPHERE;

ANGIOCARDIOGRAPHY; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY COLLATERAL CIRCULATION; DOG; DRUG DISTRIBUTION; DRUG RETENTION; DRUG UPTAKE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE REPERFUSION; HEART SCINTISCANNING; HEMODYNAMICS; NONHUMAN; SWINE;

EID: 0034073472     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050536     Document Type: Article

References (37)

1. 1. Okada RD, Glover D, Gaffney T, Williams S. Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. Circulation 1988; 77: 491-498.
2. 2. Li QS, Frank TL, Franceschi D, Wagner HN, Becker LC. Technetium-99m methoxyisobutyl isonitrile (RP-30) for quantification of myocardial ischemia and reperfusion in dogs. J Nucl Med 1988; 29: 1539-1548.
3. 3. Canby RC, Silber S, Pohost GM. Relations of the myocardial imaging agents Tc-99m MIBI and 201 myocardial blood flow in a canine model of myocardial ischemic insult. Circulation 1990; 81: 289-296.
4. 4. Verani MS, Herooudi MO, Mahmarian JJ, et al. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile. J Am Coll Cardiol 1988; 12: 1573-1581.
5. 5. English RJ, Kozlowski J, Tumeh SS, Holman BH. Technetium myocardial perfusion agents: an introduction. J Nucl Med Tech 1987; 15: 138-143.
6. 6. Heo J, Germann GA, Iskandrian AS, Askenase A, Segal BL. New myocardial perfusion imaging agents: description and applications. Am Heart J 1988; 115: 1111-1117.
7. 7. Gerundini P, Maffioli L. Cationic complexes of technetium for myocardial imaging. J Nucl Med 1989; 30: 1415-1419.
8. 8. Sinusas AJ, Trautman KA, Bergin JD, et al. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxy-isobutyl isonitrile. Circulation 1990; 82: 1424-1437.
9. 9. Beanlands RSB, Dawood F, Wen W-H, et al. Are the kinetics of technetium-99m methoxy-isobutyl isonitrile affected by cell metabolism and viability? Circulation 1990; 82: 998-1007.
10. 10. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutylisonitrile) technetium (I) in cultured chick myocardial cell: mitochondrial and plasma membrane potential-dependence. Circulation 1990; 82: 1826-1838.
11. 11. Piwnica-Worms D, Kronauge JF, Delmon L, Holman BL, March JD, Jones AG. Effect of metabolic inhibition on technetium-99m-MIBI kinetics in cultured chick myocardial cells. J Nucl Med 1990; 31: 464-472.
12. 12. Freeman I, Grunwald AM, Hoory S, Bodenheimer MM. Effect of coronary occlusion and myocardial viability on myocardial activity of technetium-99m-sestamibi. J Nucl Med 1991; 32: 292-298.
13. 99mTc-sestamibi uptake and retention during myocardial ischemia and reperfusion. Circulation 1993; 87: 2033-2042.
14. 14. Glover DK, Okada RD. Myocardial technetium-99m sestamibi kinetics after reperfusion in a canine model. Am Heart J 1993; 125: 657-666.
15. 15. Crane P, Lalibert R, Heminway S, Thoolen M, Orlandi C. Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention. Eur J Nucl Med 1993; 20: 20-25.
16. 16. Machac J. Technetium-99m-isonitrile: a perfusion or a viability agent? J Am Coll Cardiol 1989; 14: 1685-1688.
17. 17. Gross DR. Animal models in cardiovascular research, 2nd edn. Dordrecht: Kluwer Academic; 1994: 343-402.
18. 18. Staab ME, Meeker DK, Edwards WD, et al. Reliable models of severe coronary stenosis in porcine coronary arteries: lesion induction by high temperature or copper stent. J Intervent Cardiol 1997; 10:61-69.
19. 19. Longworth G, ed. The radiochemical manual. Harwell: AEA Technology plc; 1998: 261.
20. 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of acute treatment in myocardial infarction. Circulation 1989; 80: 1277-1286.
21. 21. Christian TF, Behrenbeck T, Pellikka PA, Huber KC, Chesebro JH, Gibbons RJ. Mismatches of left ventricular function and perfusion with Tc-99m-isonitrile following reperfusion therapy for acute myocardial infarctions: identification of myocardial stunning and hyperkinesia. J Am Coll Cardiol 1990; 16: 1632-1638.
22. 22. Christian TF, Gibbons RJ, Gersh BJ. The effect of infarct location on myocardial salvage assessed byTc-99m-isonitrile. J Am Coll Cardiol 1991; 17: 1303-1308.
23. 23. Christian TF, Schwartz RS, Gibbons RJ. Determinants of infarct size in reperfusion therapy for acute myocardial infarction. Circulation 1992; 86: 81-90.
24. 24. Domenech RJ, Hoffman JIE, Nole MIM, Saunders KB, Henson JR, Subijanto S. Total and regional coronary blood flow measured by radioactive microsphere in conscious and anesthesized dogs. Circ Res 1969; 25: 581-596.
25. 25. Buckberge GD, Luck JE, Payne DB, Hoffman JIE, Archie JP, Fixier DE. Some sources of error in measuring blood flow with radioactive microspheres. J Appl Physiol 1971; 31: 598-604.
26. 26. Mack CA, Patel SR, Schwartz EA, Zanzonico P, Hahn RT, Ilercil A, Devereux RB, Goldsmith SJ, Christian TF, Sanborn TA, Kovesdi I, Hackett N, Isom OW, Crystal R, Rosengart TK. Biological bypass utilizing adenovirus-mediated gene transfer of the cDNA for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg 1998; 115: 168-176.
27. 27. Leppo JA, Meerdink DJ. Comparison of the myocardial up-take of a technetium-labeled isonitrile analogue and thallium. Circ Res 1989; 65: 632-639.
28. 201Tl the presence of a severe coronary artery stenosis. Circulation 1994; 89: 2332-2341.
29. 29. Li QS, Solot A, Frank TL, Wagner HN, Becker LC. Myocardial redistribution of technetium-99m methoxyisobutyl isonitrile (SESTAMIBI). J Nucl Med 1990; 31: 1069-1076.
30. 30. Taillefer R, Primeau M, Costi P, Lambert RL Zveill ZJ, Latour Y. Technetium-99m-sestamibi myocardial perfusion imaging in detection of coronary artery disease: comparison between initial (1-hour) and delayed (3-hour) post exercise images. J Nucl Med 1991; 32: 1961-1965.
31. 99mTc-SESTAMIBI in cultured chick ventricular myocytes during ATP depletion. Circulation 1992; 85: 1531-1541.
32. 32. Reimer KA, Jennings RB. The wave front phenomenon of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979; 40: 633-644.
33. 33. Amsterdam EA, Pan HL, Rendig SV, Symons JD, Fletcher MP, Longhurst JC. Limitation of myocardial infarct size in pigs with a dual lipoxygenase-cyclooxygenase blocking agent by inhibition of neutrophil activity without reduction of neutrophil migration. J Am Coll Cardiol 1993; 22: 1738-1744.
34. 34. Granger CB, Califf RM, Topol EJ. Thrombolytic therapy for acute myocardial infraction. Drugs 1992; 44: 293-323.
35. 35. Verheugt FW, Liem A, Zijlstra F, Marsh RC, Veen G, Bronzwaer JG. High dose bolus heparin as initial therapy before primary angioplasty for acute myocardial infarction: results of the heparin in early patency (HEAP) pilot study. J Am Coll Cardiol 1998; 31: 289-293.
36. 36. Chareonthaitawee P, Christian TF, O'Connor MK, et al. Non-invasive prediction of residual blood flow within the risk area during acute myocardial infarction: a multicenter validation study of patients undergoing direct coronary angioplasty. Am Heart J 1997; 134: 639-646.
37. 37. Harada K, Friedman M, Lopez JL, Wang SY, Li J, Prasad PV, Pearlman JD, Edelman ER, Sellke FW, Simons M. Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol 1996; 270: H1791-H1802.